Yes indeed Dr @aszim13 #HER2Climb was a game changer for #brainmets. So grateful to the trial volunteers (aka heroes), investigators and sponsor @SeattleGenetics #LBBCMetsConf

I’m not #HER2. I don’t have #brainmets. The results from #HER2Climb and the hope it provides to my friends with HER2+ disease made me cry tears of joy. #SABCS19 #oncoalert #bcsm @SeattleGenetics

For #HER2 especially with #brainmets the HUGE news is #HER2climb using @SeattleGenetics Tucatinib. Huge because the trial included untreated/active brain mets and these patients had amazing results. 1/2 #SABCS19 #oncoalert #bcsm

Yay @lianne_kraemer for asking why #DESTINY excluded patients with active #brainmets. This was a lost opportunity to potentially benefit people, as #HER2Climb showed! #SABCS19 #oncoalert #bcsm #StopExcludingBrainMets!

Discontinuation rates with Tucatinib were low in #HER2Climb #SABCS19 #oncoalert #bcsm

Of course the app and ability to screenshot slides isn’t working when #HER2Climb is being presented! Improved OS with Tucatinib including patients with brain mets #SABCS19 #oncoalert #bcsm